Adaptive Biotechnologies (ADPT) Shares Outstanding (2018 - 2025)
Historic Shares Outstanding for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $152.6 million.
- Adaptive Biotechnologies' Shares Outstanding rose 340.16% to $152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.6 million, marking a year-over-year increase of 340.16%. This contributed to the annual value of $147.8 million for FY2024, which is 185.51% up from last year.
- As of Q3 2025, Adaptive Biotechnologies' Shares Outstanding stood at $152.6 million, which was up 340.16% from $152.2 million recorded in Q2 2025.
- Adaptive Biotechnologies' Shares Outstanding's 5-year high stood at $152.6 million during Q3 2025, with a 5-year trough of $139.9 million in Q1 2021.
- Its 5-year average for Shares Outstanding is $145.2 million, with a median of $144.6 million in 2023.
- In the last 5 years, Adaptive Biotechnologies' Shares Outstanding soared by 1047.44% in 2021 and then surged by 121.02% in 2022.
- Adaptive Biotechnologies' Shares Outstanding (Quarter) stood at $141.4 million in 2021, then rose by 1.21% to $143.1 million in 2022, then rose by 1.38% to $145.1 million in 2023, then grew by 1.86% to $147.8 million in 2024, then grew by 3.25% to $152.6 million in 2025.
- Its Shares Outstanding stands at $152.6 million for Q3 2025, versus $152.2 million for Q2 2025 and $151.9 million for Q1 2025.